Download PDF

1. Company Snapshot

1.a. Company Description

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases.It operates eight hospitals and 5,420 beds/places at five medical sites.


The company is based in Bad Neustadt an der Saale, Germany.

Show Full description

1.b. Last Insights on RHK

RHÖN-KLINIKUM's recent performance was negatively impacted by a decline in earnings per share (EPS) to €0.11 in Q1 2025, down from €0.16 in the same period last year. The company's revenue growth, although still positive at 5.3%, slowed compared to the previous quarter. Additionally, the European market's heightened uncertainty due to unexpected U.S. trade tariffs and the subsequent decline in the STOXX Europe 600 Index have likely contributed to the company's recent challenges. Furthermore, the easing of tariff concerns and economic growth in the eurozone have not yet translated into significant benefits for RHÖN-KLINIKUM's operations.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

LVMH: Share transactions disclosure

Sep -09

Source:

Card image cap

What Does the Steep 20% Drop Mean for Rémy Cointreau’s 2025 Outlook?

Sep -09

Source:

Card image cap

Société Foncière Lyonnaise (ENXTPA:FLY): Assessing Valuation After a Year of Solid Share Price Gains

Sep -09

Source:

Card image cap

Minor Hotels Europe & Americas (BME:NHH): Exploring Valuation After Steady Share Performance

Sep -09

Source:

Card image cap

What Recent Earnings Mean for Forvia’s 2025 Value Prospects

Sep -09

Source:

Card image cap

Assessing Veolia Environnement (ENXTPA:VIE) Valuation as Investors Eye Subtle Shifts in Utility Stocks

Sep -09

Source:

Card image cap

Telenor (OB:TEL): Is the Market Underestimating Its True Value?

Sep -09

Source:

Card image cap

How Will Vivendi’s Q1 Earnings Miss Impact Its 2025 Market Valuation?

Sep -09

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (2.48%)

6. Segments

Acute Hospitals

Expected Growth: 2.5%

RHÖN-KLINIKUM's Acute Hospitals segment growth of 2.5% is driven by increasing demand for healthcare services, strategic partnerships, and investments in digitalization and process optimization. Additionally, the segment benefits from a strong reputation, high-quality medical services, and a solid financial position, enabling the company to invest in growth initiatives and expand its market share.

Rehabilitation Hospitals

Expected Growth: 1.8%

Rehabilitation Hospitals from RHÖN-KLINIKUM Aktiengesellschaft's 1.8% growth is driven by increasing demand for post-acute care, aging population, and government initiatives promoting rehabilitation services. Additionally, the company's focus on specialized rehabilitation programs, strategic partnerships, and investments in digital healthcare solutions contribute to its growth.

Medical Care Centres

Expected Growth: 2.2%

RHÖN-KLINIKUM's 2.2% growth in Medical Care Centres is driven by increasing demand for healthcare services, an aging population, and strategic partnerships. Additionally, investments in digitalization and process optimization have improved operational efficiency, allowing for better resource allocation and cost savings. These factors have contributed to the segment's steady growth.

7. Detailed Products

Hospital Services

RHÖN-KLINIKUM Aktiengesellschaft provides comprehensive hospital services, including inpatient and outpatient care, emergency medicine, and surgical services.

Diagnostic Services

The company offers a range of diagnostic services, including laboratory tests, imaging services, and pathology services.

Rehabilitation Services

RHÖN-KLINIKUM Aktiengesellschaft provides rehabilitation services, including physical therapy, occupational therapy, and speech therapy.

Outpatient Services

The company offers outpatient services, including doctor's offices, medical centers, and specialized clinics.

Telemedicine Services

RHÖN-KLINIKUM Aktiengesellschaft provides telemedicine services, allowing patients to remotely consult with healthcare professionals.

Medical Research and Education

The company is involved in medical research and education, providing training and education for healthcare professionals.

8. RHÖN-KLINIKUM Aktiengesellschaft's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for RHÖN-KLINIKUM Aktiengesellschaft is medium due to the presence of alternative healthcare providers and medical tourism.

Bargaining Power Of Customers

The bargaining power of customers for RHÖN-KLINIKUM Aktiengesellschaft is low due to the lack of negotiating power of individual patients.

Bargaining Power Of Suppliers

The bargaining power of suppliers for RHÖN-KLINIKUM Aktiengesellschaft is medium due to the presence of multiple suppliers of medical equipment and pharmaceuticals.

Threat Of New Entrants

The threat of new entrants for RHÖN-KLINIKUM Aktiengesellschaft is low due to the high barriers to entry in the healthcare industry.

Intensity Of Rivalry

The intensity of rivalry for RHÖN-KLINIKUM Aktiengesellschaft is high due to the presence of multiple competitors in the healthcare industry.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 10.41%
Debt Cost 3.95%
Equity Weight 89.59%
Equity Cost 3.58%
WACC 3.62%
Leverage 11.62%

11. Quality Control: RHÖN-KLINIKUM Aktiengesellschaft passed 6 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Terveystalo

A-Score: 6.2/10

Value: 6.8

Growth: 5.4

Quality: 6.1

Yield: 7.5

Momentum: 5.0

Volatility: 6.7

1-Year Total Return ->

View Full Report
Stock-Card
LNA Santé

A-Score: 4.9/10

Value: 8.4

Growth: 4.6

Quality: 3.1

Yield: 3.1

Momentum: 6.0

Volatility: 4.3

1-Year Total Return ->

View Full Report
Stock-Card
Spire Healthcare

A-Score: 4.4/10

Value: 5.4

Growth: 6.4

Quality: 2.4

Yield: 0.6

Momentum: 6.0

Volatility: 5.3

1-Year Total Return ->

View Full Report
Stock-Card
Aevis Victoria

A-Score: 4.4/10

Value: 2.9

Growth: 4.8

Quality: 3.4

Yield: 2.5

Momentum: 5.5

Volatility: 7.0

1-Year Total Return ->

View Full Report
Stock-Card
RHOEN-KLINIKUM

A-Score: 4.3/10

Value: 7.9

Growth: 5.6

Quality: 5.2

Yield: 0.6

Momentum: 1.5

Volatility: 5.0

1-Year Total Return ->

View Full Report
Stock-Card
Ramsay Santé

A-Score: 3.8/10

Value: 8.9

Growth: 3.9

Quality: 1.7

Yield: 0.0

Momentum: 1.0

Volatility: 7.3

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

12.5$

Current Price

12.5$

Potential

-0.00%

Expected Cash-Flows